Literature DB >> 21039546

New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.

Anette Müllertz1, Anayo Ogbonna, Shan Ren, Thomas Rades.   

Abstract

OBJECTIVES: The aim of this review is to highlight relevant considerations when implementing a rational strategy for the development of lipid and surfactant based drug delivery system and to discuss shortcomings and challenges to the current classification of these delivery systems. We also aim to offer suggestions for an improved classification system that will accommodate lipid based formulations that are not currently accommodated in the lipid formulation classification system. KEY
FINDINGS: When categorising lipid and surfactant based drug delivery systems, the current Lipid Formulations Classifications System is a useful tool. However, it does not apply to all marketed lipid and surfactant systems or those reported in research papers. A more profound understanding of the functionalities of lipids and surfactants and their role in emulsion formation will enable a rational development strategy and will create the basis for a revised classification system encompassing all employed lipid and surfactant drug delivery systems.
SUMMARY: The ever-increasing number of poorly soluble compounds in drug discovery and development calls for the serious need for effective and affordable drug delivery strategies that will enhance bioavailability and decrease variability. Lipid and surfactant based drug delivery systems offer these advantages; however, the development of these systems requires proper understanding of the physicochemical nature of the compound as well as the lipid excipients and gastrointestinal digestion. One major challenge of lipid excipients and delivery systems is the varying range of compounds they contain. This has contributed to the challenge of proper characterisation and evaluation of these delivery systems, their stability, classification and regulatory issues, which consequently have affected the number of these formulations that eventually reach the market. Suggestions as to proper classification of these delivery systems based on their main lipid component and recommended use are put forward. The prospect of these delivery systems looks promising.
© 2010 The Authors. Journal compilation © 2010 Royal Pharmaceutical Society of Great Britain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21039546     DOI: 10.1111/j.2042-7158.2010.01107.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  30 in total

1.  Nanoemulsion-based delivery systems for poorly water-soluble bioactive compounds: Influence of formulation parameters on Polymethoxyflavone crystallization.

Authors:  Yan Li; Jinkai Zheng; Hang Xiao; David Julian McClements
Journal:  Food Hydrocoll       Date:  2011-09-17       Impact factor: 9.147

2.  Understanding biorelevant drug release from a novel thermoplastic capsule by considering microstructural formulation changes during hydration.

Authors:  Zdravka Misic; Raphael Urbani; Thomas Pfohl; Katharina Muffler; Georg Sydow; Martin Kuentz
Journal:  Pharm Res       Date:  2013-08-07       Impact factor: 4.200

Review 3.  Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations.

Authors:  Cheng Loong Ngan; Azren Aida Asmawi
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

4.  The effect of composition and gastric conditions on the self-emulsification process of ibuprofen-loaded self-emulsifying drug delivery systems: a microscopic and dynamic gastric model study.

Authors:  Annalisa Mercuri; Antonio Passalacqua; Martin S J Wickham; Richard M Faulks; Duncan Q M Craig; Susan A Barker
Journal:  Pharm Res       Date:  2011-02-24       Impact factor: 4.200

5.  Using Environment-Sensitive Fluorescent Probes to Characterize Liquid-Liquid Phase Separation in Supersaturated Solutions of Poorly Water Soluble Compounds.

Authors:  Shweta A Raina; David E Alonzo; Geoff G Z Zhang; Yi Gao; Lynne S Taylor
Journal:  Pharm Res       Date:  2015-06-27       Impact factor: 4.200

6.  Impact of Solubilizing Additives on Supersaturation and Membrane Transport of Drugs.

Authors:  Shweta A Raina; Geoff G Z Zhang; David E Alonzo; Jianwei Wu; Donghua Zhu; Nathaniel D Catron; Yi Gao; Lynne S Taylor
Journal:  Pharm Res       Date:  2015-05-28       Impact factor: 4.200

7.  Influence of drug load and physical form of cinnarizine in new SNEDDS dosing regimens: in vivo and in vitro evaluations.

Authors:  Scheyla D V S Siqueira; Anette Müllertz; Kirsten Gräeser; Georgia Kasten; Huiling Mu; Thomas Rades
Journal:  AAPS J       Date:  2017-01-09       Impact factor: 4.009

8.  Role of nanoparticle size, shape and surface chemistry in oral drug delivery.

Authors:  Amrita Banerjee; Jianping Qi; Rohan Gogoi; Jessica Wong; Samir Mitragotri
Journal:  J Control Release       Date:  2016-07-30       Impact factor: 9.776

9.  Self-nanoemulsifying ramipril tablets: a novel delivery system for the enhancement of drug dissolution and stability.

Authors:  Khalid F Alhasani; Mohsin Kazi; Mohamed Abbas Ibrahim; Ahmad A Shahba; Fars K Alanazi
Journal:  Int J Nanomedicine       Date:  2019-07-18

Review 10.  Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

Authors:  Oljora Rezhdo; Lauren Speciner; Rebecca Carrier
Journal:  J Control Release       Date:  2016-08-09       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.